Internal Medicine, Interventional Cardiology · Du Bois, PA
NPI
1437155363
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Hospital Ave, Suite 211
Du Bois, PA, 15801
Phone (814) 375-3722
Groups this clinician bills Medicare through
Medicare paid, 2024
$336K
9,806 services
Medicare patients, 2024
3,028
Average age 77
Drug cost, 2024
$961K
3,391 prescriptions
Company payments, 2025
$4,250
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayaseelan Ambrose was code 93010 (electrocardiogram), 2,705 times for 1,864 patients. In total Jayaseelan Ambrose billed 9,806 services in 96 codes, and Medicare paid $336K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 2,705 | 1,864 | $5.75 | $16K |
| 93296 External Electrocardiographic Monitoring | Office | 1,583 | 503 | $13.13 | $21K |
| 93294 External Electrocardiographic Monitoring | Office | 1,108 | 351 | $18.97 | $21K |
| 93295 External Electrocardiographic Monitoring | Office | 483 | 157 | $22.85 | $11K |
| 99214 Office E&M - Established | Office | 436 | 375 | $81.37 | $35K |
| 93000 Electrocardiogram | Office | 402 | 373 | $8.82 | $3,547 |
| 93298 External Electrocardiographic Monitoring | Office | 314 | 46 | $64.72 | $20K |
| 93306 Echocardiography (TTE/TEE) | Facility | 295 | 290 | $45.25 | $13K |
| 93280 External Electrocardiographic Monitoring | Office | 286 | 250 | $52.33 | $15K |
| 99213 Office E&M - Established | Office | 230 | 214 | $60.31 | $14K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 178 | 85 | $24.11 | $4,292 |
| 93290 External Electrocardiographic Monitoring | Office | 161 | 141 | $29.91 | $4,815 |
| 76937 Ultrasound - Nonspecific | Facility | 125 | 81 | $10.52 | $1,315 |
| 93306 Echocardiography (TTE/TEE) | Office | 107 | 107 | $123.87 | $13K |
| 99215 Office E&M - Established | Office | 93 | 91 | $127.15 | $12K |
By year: 2022 $356K for 9,064 services; 2023 $361K for 10,023 services; 2024 $336K for 9,806 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jayaseelan Ambrose prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 425 prescriptions and refills. In total Jayaseelan Ambrose wrote 3,391 Medicare prescriptions that cost $961K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 425 | 587 | 95 | $374K |
| Metoprolol Succinate Generic | 413 | 908 | 139 | $6,652 |
| Eliquis Apixaban | 203 | 339 | 50 | $192K |
| Spironolactone Generic | 197 | 472 | 80 | $1,716 |
| Torsemide Generic | 180 | 345 | 70 | $2,092 |
| Carvedilol Generic | 156 | 354 | 51 | $1,017 |
| Atorvastatin Calcium Generic | 134 | 327 | 42 | $1,544 |
| Farxiga Dapagliflozin Propanediol | 127 | 202 | 39 | $110K |
| Amiodarone Hcl Generic | 109 | 255 | 48 | $2,372 |
| Jardiance Empagliflozin | 106 | 188 | 30 | $107K |
| Acebutolol Hcl Generic | 101 | 181 | 30 | $5,719 |
| Amlodipine Besylate Generic | 95 | 219 | 39 | $587 |
| Valsartan Generic | 83 | 166 | 24 | $3,055 |
| Clopidogrel Clopidogrel Bisulfate | 78 | 196 | 34 | $966 |
| Rosuvastatin Calcium Generic | 75 | 193 | 26 | $1,123 |
Brand drugs: 1,068 claims; generic drugs: 2,323 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayaseelan Ambrose $4,250 ($4,250 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbott Laboratories with $3,482.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.